Get 20% lifetime commission for referring investors to digrin.com
here.
Keros Therapeutics, Inc. ( KROS) - Stock Earnings
KROS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
KROS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.5 million USD | 385000 USD |
| 2026Q1 | -23.7 million USD | 367000 USD |
| 2026Q2 | -28.7 million USD | 18.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
KROS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.0 million USD | 151000 USD |
| 2024 | -187.4 million USD | 3.6 million USD |
| 2025 | 87.0 million USD | 244.1 million USD |
| 2026 Est. | — | — |
KROS
Price: $10.66
52 week price:
Earnings Per Share: -3.22 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 412500
Market Capitalization: 225.2 million